Fortrea Holdings Inc. filings document the public-company disclosures of a Nasdaq-listed contract research organization. The company’s 8-K reports furnish operating results and financial condition updates, including revenue, profitability measures, book-to-bill metrics, guidance and related press release exhibits.
Fortrea’s regulatory filings also cover proxy governance, annual meeting matters, board composition, executive compensation and inducement award plans. Capital-structure disclosures include common stock, rights to purchase Series A preferred stock, senior secured notes activity and other debt or equity matters tied to the company’s clinical development services business.
FTRE submitted Form 144 notices reporting proposed sales of Common Stock tied to restricted stock vesting. The filing lists a proposed sale of 4,866 shares on 06/01/2026 described as Restricted Stock Vesting under Compensation. The filing also lists prior sales by Jill G. McConnell of 5,061 shares on 03/10/2026 and 1,804 shares on 03/16/2026.
FTRE files a Form 144 notice to sell 4,866 shares of Common Stock. The shares are described as restricted stock vesting with a vesting date of 06/01/2026 and are noted as compensation. The filing lists prior sales by Mark A. Morais of 4,599 shares on 03/10/2026 and 1,804 shares on 03/16/2026, with corresponding amounts shown.
Fortrea Holdings Inc. Chief Accounting Officer Robert Parks sold 2,000 shares of Common Stock in an open-market transaction at $13.44 per share. After this sale, he directly holds 20,389 shares of Fortrea common stock. The filing describes this as a straightforward sale by the reporting person, with no derivatives involved.
Fortrea Holdings Inc. director Peter M. Neupert reported a routine equity compensation event. On May 14, 2026, he settled 148,536 Restricted Stock Units into the same number of shares of Fortrea common stock on their scheduled vesting date. Following this vesting and conversion, he holds an aggregate of 246,668 shares of common stock directly. The filing reflects an exercise/conversion of RSUs rather than an open-market purchase or sale.
FTRE filed a Form 144 reporting proposed dispositions of restricted common shares vesting on and a prior sale by an affiliate.
The filing lists restricted stock vesting of 1,450 shares on 09/06/2025 and 550 shares on 09/13/2025. It also reports that Robert A. Parks sold 1,927 shares on 03/10/2026 for $17,479.62.
Fortrea Holdings Inc. reported first-quarter 2026 results, with revenue of $636.5 million compared to $651.3 million a year earlier. GAAP net loss narrowed sharply to $23.6 million, or $(0.25) per diluted share, versus a prior-year net loss of $562.9 million, which included a large non-cash goodwill impairment.
On a non-GAAP basis, adjusted EBITDA rose to $47.0 million from $30.3 million, and adjusted net income increased to $15.2 million, or $0.16 per diluted share, from $1.9 million. The book-to-bill ratio was 1.15x and backlog was $7,846 million as of March 31, 2026. The company reaffirmed full-year 2026 guidance for revenue of $2,550–$2,650 million and adjusted EBITDA of $190–$220 million.
Fortrea Holdings Inc Schedule 13G: Vanguard Capital Management reports beneficial ownership of 4,728,735 shares of Common Stock, representing 5.05% of the class as of 03/31/2026. The filer reports sole dispositive power over 4,728,735 shares and sole voting power for 690,173 shares. The filing is signed on 04/29/2026.
Fortrea Holdings Inc. is asking stockholders to vote at its virtual 2026 Annual Meeting on June 9, 2026. Stockholders will elect three Class III directors to serve until the 2028 meeting, ratify Deloitte & Touche LLP as auditor for 2026, and approve an advisory Say‑on‑Pay vote.
The record date is April 15, 2026, when 94,584,730 shares of common stock were outstanding, each with one vote. Fortrea describes its board committees, director independence, declassification of the board by 2028, and a global CRO business with approximately 14,300 employees operating in about 100 countries.
The proxy explains executive compensation philosophy, heavy use of performance-based pay, and 2025 actions, including a $1,100,000 base salary and 150% target bonus opportunity for CEO Anshul Thakral and a monthly $100,000 salary for interim CEO Peter Neupert. It also reports that 2025 Say‑on‑Pay support exceeded 94% and that Deloitte audit fees were $3,888,907 in 2025.